I always like the Fall, the "season of mists and mellow fruitfulness". It was the Autumn Equinox recently, and here in the UK, we are enjoying that lovely balance of weather at the turning of the seasons, the slow change from summer to fall, autumn fruits ripening, nights starting to draw in.
And of course this means our thoughts turn to… the Linguamatics Text Mining Summit! Held on the East Coast, this is an opportunity for our text mining community, across both healthcare and pharma industries, to come together. Attendees share best practice, get some hands-on training, and listen to talks on how others are finding real value from their textual data, using the power of NLP-based text mining.
This year, we will be in New Castle, New Hampshire, and the main talks will be on Tuesday 2nd October and Wednesday 3rd October. As always we have a balance of talks from our life science and healthcare customers, and from Linguamatics presenters, providing updates on current and future developments and plans. Our customer speakers encompass a wide range of use cases, spanning drug discovery and development, and into clinical delivery of therapeutics and better patient care.
One interesting thread through many of these talks is the growing use of I2E for textual ETL (extract-transform-load) workflows, where NLP is used to extract facts and relationships from free text that are then loaded into databases. These databases are used for analytics pipelines to support decision support, sometimes using web portals or dashboards to allow a much broader audience of end-users to gain value from the data. Linguamatics recognize this demand for better programmatic, and democratic, access to text mining, and we will also be presenting on some of the developments to power this, across the business enterprise.
- Dongyu Liu, Associate Director, Science Computing, Sanofi Genzyme, will be talking on using I2E to search the literature to annotate the association of the human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity. Dongyu’s team have built up a curated text mined database of phenotype-genotype associations, to assist biomarker projects in drug development.
- David Birtwell, Director of Informatics at Penn Medicine BioBank will discuss the advantages of using NLP to identify patient phenotypes from clinical reports. Bio-specimens and the data gained by their analysis are valuable resources for bio-medical investigators. The Penn Medicine BioBank supports researchers by providing centralized access to a large number of annotated blood and tissue samples.
- Peter Hornbeck, Director of PhosphoSite, will be talking about how researchers at CST use NLP to reveal the language of cells, and the nature of cellular communication. Cell Signaling Technology utilize text mining to provide comprehensive information around protein post-translational modifications (PTMs) including phosphorylation, ubiquitination, acetylation and methylation.
- Pfizer have been pioneering the use of I2E for document quality review, and Bryan Morganti, Business Partner at Pfizer, will present how Pfizer are now productising NLP for error checking at the Blinded Data Review stage in the QA/QC process of FDA submission packages.
- Lue-Yen Tucker, Senior Data Consultant at Kaiser Permanente, will present on the use of NLP to extract valuable patient information from electronic medical records such as Pathology Reports and Operating Notes.
- Ross Martin, Program Director, Research and Transformation at CRISP (Chesapeake Regional Information System for our Patients), will discuss applications for NLP in a real-world, mission critical setting for identifying relevant information in a sea of data, informing clinical decision support, improving quality measures, and monitoring public and population health.
- Getting better value from data across the enterprise is of course important for all organizations. Tony Sheaffer, MDM Account Executive at Informatica, will talk about using a master data management model for a patient, product or customer 360 degree view.
- Allen Murvine (Director of NLP Products and Services) and Roger Gildersleeve (Senior Clinical Terminologist) from IMO (Intelligent Medical Objects) look at bridging the gap between clinical language and complex medical coding, and use of NLP to tackle the clinical documentation burden. The combination of IMO terminologies with Linguamatics I2E enables clinical concepts to be accurately extracted from unstructured free text enabling the automation of physician documentation workflows.
So, if you can, come and join us at beautiful Wentworth by the Sea in New Castle, New Hampshire, for some stimulating discussions and valuable networking.